Dolby Laboratories (NYSE:DLB) CAO Ryan Nicholson Sells 357 Shares

Dolby Laboratories (NYSE:DLB) CAO Ryan Nicholson sold 357 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $60.63, for a total value of $21,644.91. Following the transaction, the chief accounting officer owned 36,984 shares of the company’s stock, valued at approximately $2,242,339.92. This represents a 0.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Dolby Laboratories Trading Down 0.8%

Dolby Laboratories stock opened at $60.87 on Friday. Dolby Laboratories has a 12 month low of $48.26 and a 12 month high of $75.66. The stock’s 50 day simple moving average is $52.70 and its two-hundred day simple moving average is $58.47. The firm has a market cap of $5.76 billion, a PE ratio of 25.90 and a beta of 0.80.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business had revenue of $305.00 million for the quarter, compared to analysts’ expectations of $311.96 million. During the same quarter last year, the company earned $0.78 EPS. The business’s revenue was down 3.3% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, equities research analysts forecast that Dolby Laboratories will post 3.21 EPS for the current year.

Dolby Laboratories announced that its board has initiated a stock repurchase program on Thursday, July 30th that permits the company to buyback $350.00 million in outstanding shares. This buyback authorization permits the electronics maker to purchase up to 7% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th will be given a $0.36 dividend. The ex-dividend date is Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.4%. Dolby Laboratories’s dividend payout ratio is 61.28%.

Analyst Upgrades and Downgrades

DLB has been the subject of several recent analyst reports. Rosenblatt Securities restated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, July 31st. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Wednesday, June 24th. Finally, Barrington Research reissued an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, June 15th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $90.75.

Institutional Trading of Dolby Laboratories

Large investors have recently made changes to their positions in the company. Bank of New York Mellon Corp purchased a new position in Dolby Laboratories in the 2nd quarter valued at $253,289,000. Wedge Capital Management L L P NC raised its position in shares of Dolby Laboratories by 53.2% in the second quarter. Wedge Capital Management L L P NC now owns 77,380 shares of the electronics maker’s stock valued at $4,069,000 after buying an additional 26,860 shares during the last quarter. Handelsbanken Fonder AB raised its position in shares of Dolby Laboratories by 31.0% in the second quarter. Handelsbanken Fonder AB now owns 23,216 shares of the electronics maker’s stock valued at $1,221,000 after buying an additional 5,500 shares during the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of Dolby Laboratories by 88.9% in the second quarter. Assenagon Asset Management S.A. now owns 104,202 shares of the electronics maker’s stock worth $5,479,000 after buying an additional 49,044 shares in the last quarter. Finally, CX Institutional lifted its stake in shares of Dolby Laboratories by 14.4% in the second quarter. CX Institutional now owns 12,727 shares of the electronics maker’s stock worth $669,000 after buying an additional 1,605 shares in the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.